Articles

A simple blood test has been created that can detect the beginning stages of cancer, before symptoms like coughing and weight loss start. Developed by Kansas State University professors Stefan Bossmann and Deryl Troyer, the test can detect breast cancer and non–small cell lung cancer in less than an hour. Read More ›

The success rate of clinical trials for breast cancer drugs can increase by almost 50% when biological markers are used, according to new research from the University of Toronto Mississauga. Read More ›

By determining how water moves through tissue, water diffusion measurements with MRI could decrease false-positive breast cancer results and reduce preventable biopsies, according to recent study findings. Researchers add that the technique could also improve patient management by distinguishing high-risk lesions from other nonmalignant subtypes. Read More ›

Nursing team leaders can create a stronger commitment to safe practices and reduce the error rate among their team by having their own patient-safety actions mirror their spoken words, according to study results appearing online in the Journal of Applied Psychology. Read More ›

Vandetanib (Zactima) received full approval from the US Food and Drug Administration (FDA) for patients with nonresectable or metastatic medullary thyroid cancer (MTC). Vandetanib was initially approved under the FDA’s orphan drug program, becoming the first medical treatment for MTC.

Read More ›

Higher levels of anxiety in men who undergo surgical removal of prostate cancer appear to be linked to poor sexual satisfaction and depression, say researchers. A recent Mayo Clinic study determined that men who experience high levels of “cancer-specific anxiety” within 1 year of surgery for prostate cancer could likely benefit from counseling for anxiety, depression, and to improve their quality of life. Read More ›

Treating breast cancer in postmenopausal women with aromatase inhibitors leads to high degrees of sexual difficulties. Read More ›

According to a retrospective study published in Breast Cancer Research and Treatment, when both black and white women received regular breast cancer screening (a mammogram within 2 years of breast cancer diagnosis) there was no disparity in the number of women who presented with late-stage disease. Read More ›

More than 10 years after diagnosis, women with the most common and least aggressive subtype of breast cancer were still at risk of death from the disease, according to a Kaiser Permanente study. Read More ›

Researchers have discovered a significant link between antibodies for multiple oral bacteria and the risk of pancreatic cancer. Read More ›